Status: Recruiting
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
This study assess the Diagnostic Performance of \[18F\]PSMA-1007 PET/CT Imaging in Patients with Newly-Diagnosed High-Risk or Very-High-Risk Prostate Cancer
Participants needed: 434
Trial details
Phase: Phase 3Age: 18+Biological sex: MaleType: InterventionalSponsor: ABX advanced biochemical compounds GmbHUpdated: Nov 4, 2026Locations: 19
Eligibility criteria
The patient (male) is aged 18 years or above. [+6]
Patients for whom radical prostatectomy is not clinically appropriate or the pat... [+10]